![](/themes/defeatdd/img/inline-images/blogoverlay2.png)
Dr. Mark Alderson
![](/sites/default/files/SIIPL_manufacturing_PATH_Satvir_Malhotra.max-1440x960.jpg)
Dec 20, 2019
A worker at Serum Institute of India inspects vaccine vials at the company’s vaccine manufacturing division where PNEUMOSIL® and other conjugate vaccines are made. Photo: PATH/Satvir Malhotra.
Editor's note: The World Health Organization and
Blog
![](/sites/default/files/blog1.jpg)
Nov 12, 2015
Together, pneumonia and diarrhea kill more children under the age of five each year than any other infectious disease. Luckily, a number of prevention and treatment solutions (like vaccine delivery systems, handwashing/sanitation, antibiotics, and
Blog
![](/sites/default/files/July-18-13-540x359.jpg)
Mar 10, 2014
Reposted from the PATH blog
Pneumococcal disease prevention is a key component of the integrated effort to reduce child mortality from pneumonia and diarrhea—the two leading killers of children. The global health community is hitting these
Blog
![](/sites/default/files/richard-franco.jpg)
Apr 26, 2013
Dr. Mark Alderson is the director of the pneumococcal vaccine project at PATH. Since 2006, his team has been advancing the development of vaccines tailor-made to protect the world's poorest children from pneumonia—a disease that, together with
Blog